Skip to main content
. 2024 Mar 19;2024:7950925. doi: 10.1155/2024/7950925

Table 2.

Prevalence of stroke pre- and post-HU use among participants (n = 228).

Variables n (%)
Stroke status pre-hydroxyurea use
 Yes 28 (12.3)
 No 200 (87.7)
Stroke status post-hydroxyurea use
 Yes 6 (2.6)
 No 222 (97.4)
 Range of hydroxyurea used per week in mg (minimum-maximum) 6000 (1000–7000)  
Dosage of HU used per week (mg)
 <3500 59 (25.9)
 3500 132 (57.9)
 >3500 37 (16.2)
Duration of HU use
 < 2 years 132 (57.9)
 ≥ 2 years 96 (42.1)